AstraZeneca will invest an additional $90 million in Vietnam for drug production

Stepping Into 2023 | Ten Investors' Insights into Opportunities and Challenges for Chinese

Many years from now, this generation will have aged and retired. We may imagine an elderly retiree sitting on a wheelchair pushed by the ‘bicentennial man’ or similar robot helper, admiring a holographic projection of the California Sunset, and sipping from a cup of biochemical coffee which prevents aging.

CRM Software Provider EC Nets more than 100 Mn in Series D2

Business services are quietly changing. In the past, traditional CRM vendors have never been able to solve the problems of high costs of home-grown PaaS, long delivery cycles, and uncontrollable projects in the face of personalised enterprise needs. The new model of combining SaaS+PaaS will enable SaaS vendors to break out of the customisation trap.

China's Largest Cloud-based HCM Solution Provider Beisen Passed HKEx Hearing

On 20 March 2023, Beisen Holdings Limited(Chinese：北森控股） passed the HKSE hearing with Morgan Stanley and CICC as joint sponsors.

BOSS Zhipin Achieve Full Year Revenue of CNY 4,511 Mn in 2022，Net Profit Turns to Loss

Boosting employment is a key plan for China's economy in 2023. For now, there is still plenty of potential for online recruitment platforms to grow.

Pulnovo Medical: Chinese Medical Device Companies are Making Their Voices Heard Globally

‘Chinese medical device companies, represented by Pulnovo Medical, have always pursued medical innovation under the support of policies and capital. They have increasingly improved their technical innovation, strategic planning, and product competitiveness. Navigating the way through a dynamic, ever-changing market, Chinese medical device companies are making their voices heard in the global market.’